Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-release Tablets Versus Desvenlafaxine Succinate Sustained-release Tablets Targeting Anhedonia in Patients With Major Depression Disorder

Conditions: Anhedonia Interventions: Drug: Toludesvenlafaxine hydrochloride sustained-release tablets; Drug: Desvenlafaxine succinate sustained-release tablets Sponsors: Jiangsu Province Nanjing Brain Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials